טוען...
A139 AGREEMENT OF IBDOC® AND QUANTON CAL® RAPID LATERAL FLOW-BASED FECAL CALPROTECTIN TESTS WITH ACCEPTED LAB-BASED ASSAYS FOR MONITORING INFLAMMATORY BOWEL DISEASE
BACKGROUND: Fecal calprotectin (FCP) is a useful biomarker for monitoring inflammatory bowel disease, showing good correlation to endoscopic disease activity. Currently used lab tests take 2–4 weeks to return a result, limiting their usefulness. Recently, lateral flow-based rapid tests have been com...
שמור ב:
| הוצא לאור ב: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508233/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.139 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|